Section of Gastroenterology
Associate Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730
|BS||1998||University of Florida||Zoology
|MD||2002||University of Florida||Medicine
|Residency||2005||University of Chicago||Internal Medicine
|Chief Resident||2006||University of Chicago||Internal Medicine
|Fellowship||2008||University of Chicago||Medical Ethics
|Senior Fellowship||2009||University of Chicago||Medical Ethics
|Fellowship||2009||University of Chicago||Gastroenterology
Dr. Aronsohn is currently studying comparative effectiveness of hepatitis C therapeutic algorithms in the elderly population.
General hepatology, liver transplantation, Hepatitis C
- Aronsohn, A, Thistlethwaite, R, Segev, D, and Ross, LF, “How Different Conceptions of Risk are Used in the Organ Market Debate” American Journal of Transplantation, April 2010, Volume 10(4) 931-937
- Aronsohn, A and Reau, N, “Long-term Outcomes after Treatment with Interferon and Ribavirin in HCV Patients” Journal of Clinical Gastroenterology, Aug 2009,Volume 43(7) 661-71.